Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04381299 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function?

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026v7
  2. Primary completion date: Jan 15, 2024 to Dec 31, 2025
    • Study completion date: Jul 31, 2024 to Dec 31, 2025
    • Site details revised
    v6
  3. Primary completion date: Jun 30, 2022 to Jan 15, 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jul 31, 2022 to Jul 31, 2024
    • Site details revised
    v5
  4. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Aug 30, 2021 to Jun 30, 2022
    • Start date changed from estimate of Nov 1, 2020 to Apr 25, 2021
    • Study completion date: Dec 31, 2021 to Jul 31, 2022
    • Study site revised
  5. Start date: Jun 1, 2020 to Nov 1, 2020v3
  6. Primary endpoint revised
    • Secondary endpoints revised (4)
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A-PRP (Autologous Platelet Rich Plasma) is becoming widely used in a variety of medical procedures seeking tissue remodeling and/or healing as an intervention. To date, applications in orthopedics, wound healing, dermatology and plastic surgery have gained general acceptance, primarily as the role of platelets and their activation in tissue repair and recovery has become better understood at a cellular and molecular level. This study will involve adult women with a diagnosis of Premature ovarian insufficiency (POI) willing to perform an IVF/ICSI treatment.
Trial Details
NCT Number NCT04381299
Lead Sponsor ART Fertility Clinics LLC
Conditions
(from sponsor)		 Infertility, IVF, Premature Ovarian Failure, Anti-Mullerian Hormone Deficiency
Related terms Infertility, Primary Ovarian Insufficiency
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov